Tolerability and efficacy of BRAF and MEK inhibitors for metastasized melanoma after intra-class switch: a multicenter, retrospective study - Salzmann, M.; Wald, A.; Stege, H.; Loquai, C.; Zimmer, L.; Hayani, K.; Heinzerling, Lucie; Gutzmer, R.; Enk, A.; Hassel, J. C. (JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2022)
CRIS-Team WoS Importer:2022-09-23